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ABSTRACT
Objective: To identify knowledge produced about drug utilization by the elderly in 
the primary health care context from 2006 to 2014. Method: An integrative review 
of the PubMed, LILACS, BDENF, and SCOPUS databases, including qualitative 
research papers in Portuguese, English, and Spanish. It excluded papers with insufficient 
information regarding the methodological description. Results: Search found 633 papers 
that, after being subjected to the inclusion and exclusion criteria, made up a corpus of 76 
publications, mostly in English and produced in the United States, England, and Brazil. 
Results were pooled in eight thematic categories showing the current trend of drug use 
in the elderly, notably the use of psychotropics, polypharmacy, the prevention of adverse 
events, and adoption of technologies to facilitate drug management by the elderly. Studies 
point out the risks posed to the elderly as a consequence of changes in metabolism and 
simultaneous use of several drugs. Conclusion: There is strong concern about improving 
communications between professionals and the elderly in order to promote an exchange 
of information about therapy, and in this way prevent major health complications in this 
population.
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INTRODUCTION
The aging process can lead to changes that may affect 
drug metabolism. This is a concerning fact, mainly regard-
ing how the elderly experience the daily use of medications, 
and especially if we take into consideration the potential 
complications in terms of their health.
One should keep in mind that aging is not a homoge-
neous process. Each patient presents with individual phar-
macokinetic variations including absorption, distribution, 
metabolism, and excretion of drugs(1).
Drug utilization in the elderly is truly epidemic, and 
this may be associated with different factors such as: in-
creased prevalence of chronic Non-Communicable Diseas-
es (NCD) in this population segment; high health medi-
calization reported in the last few years and propelled by 
the pharmaceutical industry’s power; and the incentive to 
prescribe drugs observed in both the training and practice 
of health professionals, among others(2).
It is worth mentioning that the frequent use of medica-
tions in the elderly can be considered as not just an attempt 
to treat comorbidities but, above all, as a way to mitigate 
common aging situations(3).
The use of several drugs, combined or not with other 
supplementary health care forms, is a common practice 
in the elderly and is frequently described in the literature 
as a current problem due to complications resulting from 
adverse reactions and their effects on health system costs. 
Other studies have identified polypharmacy and the fre-
quency of daily doses of medications as a stressing agent for 
people, for example, with type 2 diabetes mellitus(4).
In the face of this panorama, and to foster the debate 
about how drug utilization in the elderly in primary health 
care plays an important role, we suggest an integrative re-
view based on the following question: In the scientific litera-
ture between 2006 and 2014, which would be the state-of-the-
art regarding drug utilization in the elderly in the context of 
primary health care?
As this review is part of a grounded theory-based quali-
tative study, it focuses on scientific productions of a quali-
tative nature, with the goal of identifying knowledge pro-
duced about drug utilization in the elderly in the primary 
health care context from 2006 to 2014.
METHOD
This is a literature review following an integrative(5) re-
view model where productions employed a qualitative ap-
proach in studies on aging and drug utilization in primary 
health care.
Following were the databases consulted: PubMed/Med-
line (National Library of Medicine and National Institutes 
of Health); LILACS (Literatura Latino-Americana e do 
Caribe em Ciências da Saúde); BDENF (Base de Dados de 
Enfermagem); and SCOPUS.
Following were the descriptors used (all found in the 
DeCS and MESH): Drug utilization in plural and singu-
lar, with “s” and “z”; Medications; Family health Strategies 
and related terms such as “Family health”, “family health 
Program”; Primary health care and related terms such as 
“primary care”, “primary health”; Aged and terms such as 
“Aged 80 and over”, “elderly”, “older”; and Qualitative Re-
search, “qualitative study”, “qualitative studies”, “qualitative 
analysis”, “qualitative methods”.
To be considered, the articles should meet the following 
criteria:
•	 Inclusion	criteria:	Complete research articles and re-
views in Portuguese, English, and Spanish published in 
scientific journals from 2006 to 2014. This timeframe was 
selected based on the year of publication of the World 
Health Organization’s document on safe drug utilization 
in public health services(6). Only articles of a qualitative 
nature were used—in consideration of the method ad-
opted by the research of which this review is part—and 
those that provided an overview of what has been studied 
on drug utilization in the elderly in light of that approach.
•	 Exclusion	 criteria:	Editorials, reviews, experience re-
ports, and theoretical reflections; dissertations, theses, 
and monographs; and abstracts published on proceed-
ings. Repeated articles were excluded, and only the first 
version found was maintained; publications not directly 
related to the topic were also excluded. Likewise, articles 
where the methodological description had insufficient in-
formation for readers to understand the research process 
were disregarded. In this way, the documents maintained 
informed, at least: type of study; approach; population; 
data collection techniques; and tools.
Search StrategieS
PubMed/Medline
(“drug utilization” [MeSH Terms] OR “drug utilization” 
[All Fields] OR “drug utilisation” [All Fields] OR “medi-
cation” [All Fields] OR “medications” [All Fields]) AND 
(“family health” [MeSH Terms] OR “family health” [All 
Fields] OR “family health Strategies” [All Fields] OR 
“family health Strategy” [All Fields] OR “family health 
Program” [All Fields] OR “primary health care” [MeSH 
Terms] OR “primary health care” [All Fields] OR “pri-
mary care” [All Fields] OR “primary health” [All Fields]) 
AND (“aged” [MeSH Terms] OR “Aged 80 and over” 
[Mesh] OR “elderly” [All Fields] OR “older” [All Fields]) 
AND (“qualitative research” [MeSH Terms] OR (“quali-
tative” [All Fields] AND “research” [All Fields]) OR 
“qualitative research” [All Fields] OR (“qualitative” [All 
Fields] AND “study” [All Fields]) OR “qualitative study” 
[All Fields] OR (“qualitative” [All Fields] AND “stud-
ies” [All Fields]) OR “qualitative studies” [All Fields] OR 
(“qualitative” [All Fields] AND “analysis” [All Fields]) 
OR “qualitative analysis” [All Fields] OR (“qualitative” 
[All Fields] AND “methods” [All Fields]) OR “qualita-
tive methods” [All Fields] OR (“qualitative” [All Fields] 
AND “method” [All Fields]) OR “qualitative method” 
[All Fields] AND (“2006/01/01” [PDAT]: “2014/12/31” 
[PDAT]) AND (English[lang] OR Portuguese[lang] OR 
Spanish[lang])
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lilACS (viA bvS)
(“Uso de Medicamentos” OR “Utilización de Medicamentos” 
OR “Drug Utilization” OR medicamento$ OR medication$ 
OR drug$) AND (ESF OR (Estratégia AND Saúde AND 
Família$) OR (Programa AND Saúde AND Família$) OR 
PSF OR “Saúde da Familia” OR “Atenção Primária” OR 
“Atenção básica” OR “cuidados primários” OR “Estrategia de 
Salud de la Familia” OR ESF OR “Programa de Salud de la 
Familia” OR “Salud de la Familia” OR “Atención Primaria” 
OR “Atención básica” OR “family health” OR “primary care” 
OR “primary health”) AND (Idoso$ OR envelhecimento 
OR velhice OR anciano OR Aged OR elderly OR older)
bdenf (viA bvS)
(“Uso de Medicamentos” OR “Utilización de Medicamentos” 
OR “Drug Utilization” OR medicamento$ OR medication$ 
OR drug$) AND ESF OR (Estratégia AND Saúde AND 
Família$) OR (Programa AND Saúde AND Família$) OR 
PSF OR “Saúde da Familia” OR “Atenção Primária” OR 
“Atenção básica” OR “cuidados primários” OR “Estrategia de 
Salud de la Familia” OR ESF OR “Programa de Salud de la 
Familia” OR “Salud de la Familia” OR “Atención Primaria” 
OR “Atención basica” OR “family health” OR “primary care” 
OR “primary health”) AND (Idoso$ OR envelhecimento 
OR velhice OR anciano OR Aged OR elderly OR older)
SCOPuS (viA PeriódiCOS CAPeS)
(“drug utilization” OR “drug utilization” OR “medication” 
OR “medications”) AND (“family health” OR “family 
health Strategies” OR “family health strategy” OR “fam-
ily health Program” OR “primary health care” OR “primary 
care” OR “primary health”) AND (“aged” OR “Aged 80 and 
over” OR “elderly” OR “older”) AND (“qualitative research” 
OR “qualitative study” OR “qualitative studies” OR “quali-
tative analysis” OR “qualitative methods” OR “qualitative 
method”)
RESULTS
The search strategies slightly differ due to the peculiari-
ties of each database. LILACS and BDEnf did not allow 
insertions in the search strategy terms referring to quali-
tative research or time excerpt and, as such, these criteria 
were further applied. In this way, of the 315 articles initially 
identified in the LILACS using the aforementioned strat-
egy, after applying the limits “qualitative research” and its 
synonyms in addition to the time excerpt, 260 remained 
to have the abstracts analyzed. The same reduction hap-
pened with BDEnf, as the 27 articles identified through the 
search strategy, after been subjected to limits, were reduced 
to 24 articles. SCOPUS, in turn, allowed search using the 
terms “qualitative research, study, and/or method,” but the 
filters of language and time (01/01/2006 to 12/31/2014) 
had to be applied later. In this database, the use of these 
filters had no major impact on the number of articles, as 
these dropped from 182 to 181 articles subject to abstract 
analysis. PubMed/Medline was the only database consulted 
that allows the application of all limits by the time of the 
research strategy.
Figure 1 – Number of articles identified in the database according to the descriptors and limits established and the corpus selected 
for the integrative review – Santa Cruz, RN, Brazil, 2015.
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As the 76 selected articles were read, the main informa-
tion was organized in a summary table comprising: author/
year identification; article title; objective; methodology 
used; main results; and researcher remarks and/or relevant 
extracts highlighted in the article. This way of organizing 
data enabled better visualization of the information gath-
ered, helping the categorization of articles according to the 
objective of each article.
Most of the 76 articles selected to be part of the corpus 
of this review were published in 2011 (16 articles) and de-
creased in the following years: 2013 with 15; and 2012 with 
14 articles. Eight articles were identified for 2010, while 
for 2006, 2008, 2009, and 2014 five articles were published 
in each year. The year with the fewest publications on this 
topic was 2007 with three articles identified.
English was the main language (60 articles), followed 
by Portuguese (14 articles) and Spanish (two articles). The 
prevalence of publications in English does not mean that 
all articles were produced in English-speaking countries; 
rather, it shows that English is adopted as the language of 
publication by many countries, including Brazil. Most of 
the articles identified resulted from studies developed in the 
USA (27 articles), Brazil (16), England (10), Australia (six), 
New Zealand (two), Belgium, Germany, Malaysia, Holland 
(two articles each), Cuba, Denmark, Ireland, Sweden, Spain, 
Switzerland, and Singapore (one article each).
The analysis of the corpus also regarded the method-
ological path followed by the articles; however, we faced the 
following difficulty: many articles did not itemize impor-
tant methodological aspects, bringing about doubts regard-
ing what the authors did to reach such important results in 
their studies. In line with our search strategies all articles 
selected were of a qualitative nature. Some were research 
extracts with mixed methods; however, those with miss-
ing essential aspects regarding methodology were excluded. 
In this way the 76 articles making up the analyzed corpus 
showed information regarding the kind of study, approach, 
population, data collection techniques, and tools. As regards 
data collection, the semi-structured interview (used in 36 of 
the productions) stands out. While regarding data analysis 
procedures, 29 articles mentioned the adoption of content 
analysis, eight employed comparative analysis, and 14 re-
ferred to other types of analysis.
The articles that referred to the use of more than one 
data collection technology typically matched interview and 
observation(7-11) or interview and focal group(12-16), and two 
articles associated interview, observation, documentary analy-
sis, and focal group(17-18). An interesting finding was that 31 
articles mentioned the use of software to assist data han-
dling and analysis, where the most widely used was the NVi-
vo(7,9,12,15,19-27), followed by Atlas ti(28-33), Maxqda(10,34), SPSS(9,31), 
QSR 6(35-36), Excel(37-38) (two articles in each), PASW18(39), 
KWalitan 5.0(40) and Alceste(41) (one article in each).
The 76 productions analyzed were published in 56 jour-
nals with international circulation, where the most frequent 
one was BMC Family Practice with seven articles, followed by 
the British Journal of General Practice and the Journal of Gen-
eral Internal Medicine (four articles in each). In this regard, 
an important datum is that five journals were part of the 
same system, BioMed Central (BMC), owned by Springer 
Science and Business Media, a portal of science, technology, 
and medicine that includes 276 open-access journals.
Data organized in the summary table – jointly with the 
recurrent reading of integral articles – were analyzed ac-
cording to the referential adopted for the integrative review 
that allowed viewing the data, making comparisons, and 
identifying topic standards(5) leading to the classification 
of these articles into eight thematic categories. The discus-
sion of categories is grounded in the content of the articles 
selected, which structures each category.
DISCUSSION
Today daily drug utilization is a reality for the elderly 
who must deal with it as it is an important means to manage 
their health. This reality is typically found by health profes-
sionals in their everyday experience. In the face of this and 
in order to serve this population, professionals should be 
updated and rely on the literature as an important source to 
respond to the questions posed to them in their professional 
practice. This review allowed the identification of the differ-
ent views of researchers about the object of study discussed 
herein, namely drug utilization in the elderly. In this way, 
going beyond the methodological aspects of article reviews, 
this paper also tried to identify the scope of the study ob-
jects to further classify them into thematic categories that 
depict the state of the art in this matter, pooling findings 
according to their affinities.
The studies showed, as broadly discussed topics, the 
emerging issues around drug utilization security, the adop-
tion of integrative and complementary practices, the aid of 
technologies to manage drug-based treatment, the use of 
psychotropics, adherence to treatment, attitude and self-
care in those with chronic diseases, and the role played by 
the support network in the meantime. For publications on 
topics known in the literature, the researchers emphasize 
the advances and constraining factors of these studies, 
which seem to be a requirement on the part of international 
journals these days. The content of these studies is presented 
below, in eight categories defined through reading and de-
tailed analysis.
Drug utilization Security: avoiDing miStakeS anD 
potentially inappropriate DrugS (piD)
Aging causes changes in the absorption, distribution, 
bio-transformation, and elimination of drugs. The elderly 
tend to have reduced levels of serum albumin, which ren-
ders them more vulnerable to the acute effects of polyphar-
macy when several drugs that rely on protein transportation 
are prescribed together. For example, the use of warfarin 
and the risk of hemorrhage demands care, as do the benzo-
diazepines, because the elderly are more sensitive to drugs 
that act on the Central Nervous System (CNS)(42).
The use of Acetylsalicylic Acid (ASA), for example, is 
very common to prevent cardiovascular diseases; however, its 
use involves the risk of bleeding and gastric symptoms such 
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as pain, reflux, and heartburn(43). The intake of nonsteroidal 
anti-inflammatory drugs (NSAIDs) can also cause similar 
discomforts. A study done with the elderly in Australia us-
ing NSAIDs to treat osteoarthritis showed that they were 
aware of the potential damage caused by these drugs which, 
many times, were referred to “poison” or addicting prod-
ucts. These people poorly understood the adverse effects 
and controlled these by limiting the frequency and dose of 
anti-inflammatory drugs. Many of these patients assigned 
to the physician the responsibility for evaluating any risk 
related to the use of NSAIDs, as they trusted in the physi-
cian’s knowledge to make decisions about the treatment(44).
Regarding control and prevention of cardiovascular dis-
eases, some professionals consider the use of drugs accord-
ing to the patient’s race. Some American physicians state 
that there are different effects of the Angiotensin-Convert-
ing Enzyme inhibitors (ACE inhibitors) according to the 
race and therefore these are not the best option to treat high 
blood pressure in black people. However, other respondents 
recognized the potential renoprotective effect provided by 
these drugs and showed concern that black patients might 
not be taking advantage of such positive effects(45).
Three articles highlighted the common errors that affect 
security regarding drug utilization in the elderly, including 
forgetting the dosing time(46) and the professional-patient 
communication gap(23,47). In some cases patients felt as if 
they were not taken seriously during medical visits, and pro-
fessionals ended up not clarifying their doubts about the 
drugs’ adverse effects. In addition, there are misunderstand-
ings regarding information written on medical prescriptions 
in two main ways: unclear instructions that do not properly 
explain the time span between doses, and very complex in-
structions written in language that is hard for participants 
to understand(23,47).
Polypharmacy is a phenomenon that may affect safe 
drug utilization, and could be defined as the use of three or 
more drugs or of a dosage above the recommended amount. 
Many polypharmacy cases are due to lack of regular review 
of the therapeutic regime by health professionals, and also 
to the strict compliance with guidelines that many times 
leads to prescribing a large number of drugs(48). Polyphar-
macy predisposes the elderly to the risk of being prescribed 
with potentially inappropriate drugs (PID), that is, those 
where the actual or potential damages of the therapy ex-
ceed the benefits. Among the factors that can minimize 
PID are: experience; technical skill; dialogue with patients; 
incentive to review treatments; and an attitude favorable to 
non-prescription. The identification, suspension, or reduc-
tion of inappropriate drug dosages should be a priority for 
the patients’ safety(49).
For polypharmacy an option to simplify treatment, re-
duce errors, and save time is the adoption of polypills, which 
are pills with a combination of the drugs being used by the 
patient. However, there are some concerns about the safety 
and efficacy, as well as regarding the rigidity of the dose, of 
each polypill component(21).
A study performed in Rio Grande do Sul described ini-
tiatives by a program of home pharmacy care that proved 
to be efficacious in solving the problems reported by pa-
tients. It identified 13 drug-related negative effects that 
were solved in less than one month; moreover, all prob-
lems related to drugs storage were solved as well. In these 
programs, actions are performed by interdisciplinary teams, 
with the aim of evaluating whether complaints result from 
illness or are just adverse reactions. In the hypothesis of ad-
verse reactions, the prescription is changed and the patient 
is monitored to observe outcomes(50).
Another problem that affects safe drug utilization is the 
dependence on or abusive use of benzodiazepines (BZDs). 
Many chronic patients are aged individuals who began to 
trust and develop a psychological dependence on BZDs and 
their calming properties, to the point of denying or mini-
mizing the report of side effects so as to avoid having to 
cease using the drug(12,24).
Part of the elderly’s health problems can be treated by 
changing their lifestyles, as many times pharmacologic 
interventions do not have sound justification. Although 
primary care is aimed at prevention, many times this pre-
vention is through drugs. Avoiding inappropriate prescrip-
tions to prevent complications related to polypharmacy can 
improve the elderly’s quality of life(51).
the uSe of toolS/technologieS to manage Drug 
therapy
Recently Information and Communications Technolo-
gies (ICT) have been used, among other applications, to 
reduce discrepancies between the drugs listed in patients’ 
medical charts and those that patients affirm they use. This 
is a way of reducing discrepancies and helping to avoid ad-
verse events(7).
Researchers have developed and applied tools that can 
be useful and patient-friendly for both patients and profes-
sionals. Several tools were developed to identify inappro-
priate prescriptions and avoid damage to people’s health, 
particularly the elderly, who are more vulnerable to adverse 
outcomes. The STOPP & START (Screening Tool of Older 
Person’s Prescriptions and Screening Tool to Alert Doctors to 
Right Treatment), created in 2008 and popular in Europe, is 
an important tool. It is made up of two criteria rolls that ap-
proach the excesses or improper prescriptions of potentially 
inappropriate drugs (PID) and also allow for detecting the 
risk of under-prescription(17,19).
Following are some of the initiatives by professionals 
when they identify cases of PID: suspend the drug; reduce 
the dose; add another drug; or change to an alternative 
treatment(19).
An important tool that increases drug utilization safe-
ty is the Med-STEP – an online system to control blood 
pressure and allow for self-titration in patients suffering 
from hypertension and diabetes who are served by a pri-
mary health care service. The participants in the study that 
developed this tool reduced blood pressure values during 
monitoring by the research team, who assessed this out-
come as positive(15).
Warnings about prescription are another way of improv-
ing drug utilization security, and can be adopted in services 
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using electronic medical reports. Researchers from India-
napolis in the USA have developed a system that sends 
warnings as pop-ups when physicians fill in a patient’s 
prescriptions. By the time of publication the tool had two 
standardized messages: a warning when a patient was over 
65 years old, and another when a patient had a creatinine 
clearance lower than 50. The physicians participating in the 
research considered the system interface inadequate, and 
suggested that the system automatically relate changes on 
lab exams to the medications prescribed(10).
Moreover, patient-focused warnings have been devel-
oped, such as sending messages via mobile to patients with 
Chronic Obstructive Pulmonary Disease (COPD) inform-
ing them of the drug dose time and providing informa-
tion on weather conditions that contribute to reducing or 
increasing patients’ exposure to risks(52). Another proposal 
identified in this review to simplify therapy regime moni-
toring by patients was the use of a multidrug punch card. 
This strategy allows good visualization of drugs and helps to 
reminding about the doses, in addition to being a hygienic 
way of storing pills(34).
Similarly, there are simple measures that can help the 
elderly to manage drug utilization in their everyday lives, 
such as: always placing drug flasks in the same order of use; 
using phone alarms to warn about the dose time; and always 
keep some pills on the person or in a purse to prevent miss-
ing a dose(31). The use of adhesive labels on the flasks show-
ing symbols that recall the time or function of the drug, for 
example, is a useful mechanism for older patients, mainly 
those with problems reading and/or understanding the in-
structions displayed on the labels(53).
Regardless of the strategy used, we should bear in mind 
that these technologies should be built based not only on 
the opinions of experts and/or the literature, but should 
consider the opinions of those who will use these tools to 
manage their drug therapy every day(30).
the uSe of pSychotropicS
Today, anxiety and depression are disorders commonly 
found among primary health care patients, demanding 
qualified human resources to deal with these cases and, 
among other factors, help adherence to the drug therapy. 
Despite the several forms of treating people with mental 
disorders that can also help in treating depression, this last 
remains focused on drug therapy(39). A study performed in 
three primary care services in England showed that anti-
depressant drug therapy usually starts when patients have 
exhausted all other possibilities or have hit bottom. In fact, 
older people and Asian women showed more willingness 
toward following the prescription of antidepressants, stat-
ing that, in their eagerness to relieve symptoms, they would 
strictly do whatever their physicians prescribed(54).
For those using antidepressants in the US, some strate-
gies proved to be useful for elderly people to remember to 
take their medications, for example: placing the medica-
tion on the headboard when the drug is to be taken before 
bedtime, and the use trays organized by weekday to prevent 
forgetting a dose(55).
Nonetheless, the stigma related to the use of antide-
pressants remains, as some believe they are illegal and non-
natural substances that cause addiction when used for long 
periods of time. This fear is an important barrier against 
adherence to therapy, which could be worsened in some 
older people who are pessimistic regarding the chances of 
healing as they get older(35,56).
aDherence to Drug therapy
Adherence to drug therapy should not be considered 
meaningless, as it results from the subjective experiences of 
people living with given diagnoses and treatments. The fear 
of treatment and lack of information worsened by the reluc-
tance to clarify doubts with physicians are factors that hin-
der adherence to therapy(57). The lack of symptoms, blood 
pressure control of hypertensive individuals, and distance 
between home and the health service were also mentioned 
as reasons for abandoning treatment(58).
Persisting in a therapy involves personal motivation and 
self-care capacity, in addition to skills to evaluate the drug 
utilization risks and search for information(36). In the house-
hold context, treatment is influenced by the patient’s beliefs, 
living habits, and the drug characteristics(59).
Patients usually feel encouraged when professionals and 
the family provide support; however, the relation between 
this support and adhesion has not been proved. Having a 
routine that includes taking the drug or drugs is a factor that 
seems to help adherence(36). However, in some cases family 
can be a barrier to drug therapy. An example was found in 
a study performed in Malaysia with insulin-dependent dia-
betes patients, where some family members disagreed with 
the use of insulin because it is perceived as a drug for the 
elderly that causes sexual dysfunction or which is prohibited 
to Muslims, just to mention some misinterpretations(60).
In addition to insulin, another stigma was observed: the 
use of opioids. Here, barriers took the form of both resis-
tance by the family because of the fear of addiction and the 
costs of purchase, and by professionals, as these stated that 
pain evaluation is subjective and does not necessarily require 
the prescription of this class of drugs(22).
Imagining that in some situations health professionals 
may raise barriers that hinder therapy adherence is some-
thing quite intriguing and has been discussed in some of the 
articles identified. A relationship of trust between profes-
sionals and patients; the use of legible handwriting on pre-
scription forms; and leaving room to clarify doubts regard-
ing the therapy were referred to as important elements to 
be adopted to deal with the stress of multiple comorbidities 
and to adhere to treatment(11).
In some realities there is a true pilgrimage in the search 
for a drug and, when it is not available, patients follow one 
of two paths: most prefer purchasing it, even if it represents 
extra expenses to the family; others resort to judicial means 
to get the medications included in the official public lists(11). 
For this review, only one article approached the health ju-
dicialization phenomenon; it referred to a survey developed 
in the south region of Brazil and showed the difficulties 
to purchase some drugs(11). It is known that judicial means 
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have been sought in other South American countries as a 
way of having access to medications, but the scope of this 
phenomenon – national or global – cannot be ascertained, 
as we have found only one study, a Brazilian one, in a corpus 
that comprises productions from 16 different countries.
Despite the many difficulties posed by the health ser-
vice, professionals, patients, and their families, we should 
attempt to overcome the barriers, seeking strategies to solve 
or minimize the problems disclosed by the abovementioned 
studies.
In addition to the primary health care team profession-
als, the pharmacist should also be engaged in supervising 
the community members’ health in order to monitor pa-
tients and provide information. Health services might also 
employ simple but important strategies such as distribu-
tion of organizer trays to facilitate patients’ organizing their 
medications according to doses and time, which could be a 
useful tool for adherence, mainly for the elderly with mul-
tiple medications(14).
the uSe of integrative anD complementary practiceS
Altogether, we have identified five articles that ap-
proached the use of Integrative and Complementary Prac-
tices (ICP) or Alternative and Complementary Medicine 
(ACM), using the terms used by the Brazilian Ministry of 
Health and the WHO, respectively.
Some authors emphasize that, as these are natural treat-
ments, their use poses less risk to health in comparison with 
industrialized drugs, but these authors also state that these 
treatments are not free from potential adverse reactions(26). 
A study from the USA showed that the most popular 
ACM types among participants were herbs (powders, teas, 
or extracts), nutritional supplements and foods rich in soy, 
meditation, acupuncture, massage, and Reiki. Participants 
were menopausal women who explained that ACM was 
safer and less harmful than hormone therapy, claiming that 
women in previous generations were treated only with natu-
ral things(26).
For a group of older men in the mid-west region of 
Brazil, plants were viewed as different from health care unit 
drugs, as herbs took longer to be effective and could only 
help the treatment prescribed by the physician. Herbs were 
considered to be a supplementary resource and only took 
a leading role in the treatment of less serious morbidities, 
such as tea for the flu. Respondents referred to 34 medicinal 
plants, mainly guaco and lemon balm, which would serve to 
treat the flu and as calming, respectively. The meanings as-
signed to these herbs were learned from their ancestors and 
popular knowledge, reinforcing the idea that the elderly are 
the guardians of herbal medicine(61).
In the Brazilian reality, researchers who investigated the 
experience of primary and secondary healthcare patients re-
garding the use of acupuncture found the following as main 
reasons to resort to this treatment: failure of a solution to 
their problems using conventional treatments. They com-
plained about the bad effects of drugs used for long periods 
of time and saw acupuncture as an alternative, or they were 
referred to acupuncture by a physician or wanted acupunc-
ture due to complaints of pain. According to the survey, the 
primary healthcare environment seemed to favor the use of 
acupuncture and other modalities of Chinese Traditional 
Medicine (CTM)(62).
This finding is reinforced by the results of a study(37) 
where professionals advocated the importance of using al-
ternative and complementary therapies in primary health 
care, based on the following reasons: reduced financial cost 
to the SUS; fewer side effects in comparison with other 
practices; and as an alternative to the abusive use of anxio-
lytics and excessive medicalization found in health services. 
Some professionals were concerned and avoided recom-
mending herbal therapy due to the lack of technical knowl-
edge due to the short duration of medical visits, fearing that 
the patient would stop the drug therapy and in this way 
worsen their health condition.
attituDeS of the Subject regarDing DrugS
Considering that today there is a tendency towards 
increasing numbers of older people with chronic diseases, 
there is also a strong presence of continuous use of medica-
tions in this population.
Some patients believe that options diminish as the dis-
ease advances, prefer physicians to make decisions about the 
treatment, and do not seek for further information. Their 
attitudes may represent the concern or lack of concern re-
garding drug therapy in three groups: those who do not 
know what drugs are for and/or their side effects; those 
who knew the names and main side effects and relied on 
physicians to provide further information; and those who 
understood their diagnosis and were committed to always 
discovering more(63).
Among older men in Mato Grasso do Sul, the most 
commonly prescribed drugs were: captopril; hydrochloro-
thiazide; enalapril; losartan; digoxin; simvastatin; carvedilol; 
atenolol; and chlorthalidone. Here was observed the preva-
lence of everyday and permanent drugs to treat high blood 
pressure and other cardiovascular diseases and to control 
hypercholesterolemia(64).
Participants in another study did not consider high cho-
lesterol to be a disease, as there were no perceived symp-
toms, and said to treat it only with drugs because there is 
a number that shows changes in laboratory exams(13). In 
these cases, the use of drugs is a practice incorporated into 
the everyday life of these aged people and this incorpo-
ration follows the Western medical rationality model. The 
fact that life is strongly dependent on medications can lead 
to restrictions in social and personal activities, notably for 
those taking several drugs a day, regardless of whether for 
preventive reasons, for a specific treatment, or a symptom-
atic treatment(13,64-65).
A survey carried out in England with people suffering 
from chronic pain aged 62 on average showed that symp-
tomatic drugs are perceived in three ways: either as a miracle 
because they reduce pain; as drugs to be used as a last resort; 
or as a drug that provides temporary relief. People showed 
a willingness to do whatever it took to improve; however, 
first they tried to understand the cause of the pain in order 
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to treat it in a more specific way rather than exclusive with 
symptomatic drugs(20).
Women were the target of an important survey about 
osteoporosis treatment where the most influent factors re-
garding their view on the use of drugs were related to the 
drug’s effectiveness and safety, perceptions about the need 
for drug, and patients’ interactions with physicians. It seems 
that older women do not always express their concerns and 
doubts about treatment, reinforcing the importance of the 
professional’s guidance regarding their diagnosis, treatment, 
and implications(66).
An issue regarding health care to the elderly in Bra-
zil regards the supply and distribution of medications in 
primary health care, because many times this is the only 
resource available to treat multiple morbidities. Among the 
medications distributed we should mention generic drugs 
that, in some situations, are considered by older people to 
be weak, fake, or lower-quality drugs in comparison with 
the branded medicine On the other hand, there are positive 
feelings of credibility and reliability, and generic drugs are 
praised for their more affordable prices(41).
Self-care in people with non-communicable 
chronic DiSeaSeS (ncD)
People suffering from chronic diseases may report a strong 
dependence on drugs, affecting their well-being and involv-
ing costs and adverse effects. A recent study showed that 
people with high blood pressure, diabetes, and hypercholes-
terolemia took 4.8 drugs a day on average. Such consumption 
is fostered not only by individual health needs, but also by 
the strong influence of pharmaceutical industry marketing(9).
Those using polypharmacy have more chances of facing 
economic problems and thus their capacity to actively self-
manage their chronic condition and reduce risk behaviors 
is damaged. Even those eligible for government assistance 
with treatment also face economic problems, as benefits are 
typically insufficient to cope with health expenses and adopt 
healthy habits(67).
Regarding care for chronic conditions, the elderly seem 
to rank medicines, attaching priority to those for more se-
rious diseases that demand more care in usage, to the det-
riment of those they consider to relieve lesser symptoms. 
This and other behaviors of hypertensive older people are 
strategies they find to deal with multiple morbidities and 
drugs in their everyday lives(68).
Treating one or more chronic conditions implies over-
load on older people’s lives. For people with cardiovascular 
diseases, for example, this load includes the need to under-
stand treatment; self-care and interaction with family mem-
bers, professionals, and caregivers to organize care; medical 
visits; polypharmacy; and adoption of changes in lifestyle(69).
In some situations those elderly committed to dietary 
habits and exercise can present lower levels of adherence to 
the use of drugs. Low adherence to drug therapy for chronic 
diseases is probably due to the dual nature of the drugs they 
emphasize: these drugs ameliorate symptoms and improve 
life quality, but also lead to adverse reactions and the emer-
gence of new symptoms(70).
Self-monitoring is an important strategy that may be 
adopted by those who manage self-care and try to control 
chronic diseases such as high blood pressure. This review 
identified three articles that recommended this practice, as 
it motivates individuals to become more involved in their 
own care and have a better understanding of the disease. 
Measuring blood pressure at home improved the relation-
ship between patients and professionals, as they started 
discussing the values observed during medical visits(16,71-72).
Generally speaking, when people are diagnosed with 
a chronic disease, they develop new behaviors to manage 
their health, including taking drugs correctly and adopt-
ing healthy habits to take care of their health(73). However, 
sometimes accepting living with a permanent condition is 
not as simple as the literature describes. The individual’s 
engagement in self-care demands the support of family 
members and health professionals working in an interdis-
ciplinary way.
The literature confirms a common fact in professional 
practice: older people with multiple morbidities take mul-
tiple drugs. One of the reasons for this polypharmacy is the 
duplication of prescriptions, in the case of care that is not 
coordinated among the professionals taking care of the older 
person, for example. In this sense, studies of the American 
elderly treating chronic pain suggested that, if professionals 
communicated with one another and observed the notes 
of other professionals in the medical records, many double 
prescriptions would be avoided and many problems could 
be solved by seeking non-pharmacological strategies(74).
the role playeD by the Supporting network in Drug 
therapy
Researchers from Maringá, Paraná, identified at least 
three facets of the supporting network to hypertensive indi-
viduals: the formal network; the family network; and com-
munity social networks. The formal supporting network is 
represented by health professionals and plays an important 
role of support to hypertensive people in case they feel any 
symptom or to clarify doubts. However, among all profes-
sions only the physician was mentioned as the professional 
patients sought out to clarify doubts, and participants said 
that is so because physicians are responsible for the diagno-
sis and prescription of drugs(75).
At least seven other articles emphasized the sovereign 
role played by physicians in drug therapy(27-28,33,76-79). This 
can be reinforced by the fact that many people follow drug 
therapy without arguing or challenging the prescriptions 
because they completely trust their physicians(25).
In some realities there persists a relationship of domi-
nance between physicians and the elderly, characterized by 
little dialogue, scientific language that is hard for patients to 
understand, illegible handwriting, etc. All these factors lead 
to detachment and vertical interactions. However, some 
patients reported they feel respected and appraised, favor-
ing communication, improving their understanding about 
their disease, and reducing the risks related to the utilization 
of drugs(80). Communication between health professionals 
and patients seems to be a topic to be further studied in 
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health care, as another study(81) referred to it as inefficient 
competence.
Insufficient guidance on hospital discharge, for example, 
can lead to misinterpretations and misuse of drugs when the 
patient returns home after hospitalization. People have differ-
ent needs of information about drugs but, in general, say the 
ideal would be to also receive discharge guidance in writing(40).
In addition to the need for guidance, other common 
issues found regarding drug prescription by physicians are: 
non-adherence; fear about adverse effects; drug interactions 
and cost of treatment; and lack of understanding by patients 
regarding their therapy. An interesting aspect was that pa-
tients appraised a medication therapy management (MTM) 
service coordinated by pharmacists, but said that physicians 
would be better fit to that role because they know their 
patients better and have deeper clinical knowledge. Physi-
cians questioned how they would be compensated for the 
time spent in this activity when coordinating care delivered 
to their patients(28).
The role and attitudes of other health team profession-
als regarding the use of medications is also an object of 
study in many countries. The pharmacist, for example, is 
referred to in some studies as someone skilled in providing 
guidance on the rational use of medications, warning about 
side effects, and capable of mediating the physician/patient 
relationship(29,38). On the other hand, other authors(18) found 
that the natural attitude of pharmaceutics negatively affects 
care as they usually disregard the patient’s individual issues. 
These authors suggest that pharmacists should recognize, 
ask, and reflect more in their everyday practice, as patients 
want to be heard and have their experiences analyzed in an 
individual way.
Nurses were also targeted by surveys that evaluated as 
positive their engagement with medical visits and medica-
tion prescriptions; respondents said that nursing visits are 
unhurried, valuing care continuity, and providing clear and 
science-based guidance(32).
Studies have also emphasized the important role played 
by family regarding home health care to the elderly or pa-
tients with chronic diseases, because family members must 
be aware of effects, ways of using medications, and other 
aspects of the patient’s medication therapy(25,82). Among the 
strategies managed by family members we can mention: re-
ducing medication therapy costs and the adoption of natu-
ral practices, religiosity, and affectivity as care elements(8).
CONCLUSION
The results achieved in this review showed that drug uti-
lization is a broad topic that can be studied from different 
perspectives and with different methods. Here we decided 
to study this topic in the context of primary health care 
and its effects on care to the elderly, because many times 
medication therapy occupies a central axis around which 
different health aspects of aging people circulate.
As we get older, our organisms undergo changes that 
may modify the action of some drugs and either increase or 
reduce their effects. As such, to improve safety in drug utili-
zation, the studies reviewed provide some recommendations 
to health professionals that can be summarized as follows: 
review the list of home drugs and medications of each older 
person, considering the data in medical records and the in-
formation provided by them during medical visits; consider 
the peculiarities of the aging process when recommending 
a treatment; improve communication and make therapeutic 
relations more horizontal; instruct elderly patients about 
treatment and encourage the search for information; search 
for and adopt into care the use of devices/technologies that 
facilitate the identification of drugs and help the elderly to 
remember time and doses.
The adoption of these practices can bring about good 
results in health care as, for example, when we improve pro-
fessional/patient communication we can make room for the 
exchange of information, clarify doubts about treatment, 
identify complaints about adverse effects and, in this way, 
build a relationship of mutual trust and strengthen links 
with the population. When they are better informed about 
the treatment’s purposes and the risks of following it or not, 
people are better skilled for self-care, adhere more to treat-
ments, and are less exposed to complications resulting from 
the overuse or underuse of medication. Thus, numerous 
cases of iatrogenesis and hospitalization would be avoided 
in the elderly, reducing costs for the health system and their 
families, so that people’s time of life could be devoted not 
only to treating diseases, but to living with quality.
RESUMO
Objetivo: Identificar o conhecimento produzido sobre o uso de medicamentos por idosos no contexto da atenção primária à saúde, entre 
os anos de 2006 e 2014. Método: Revisão integrativa realizada nas bases de dados PubMed, LILACS, BDENF e SCOPUS, incluindo 
artigos de pesquisa qualitativa em português, inglês e espanhol. Foram excluídos aqueles cuja descrição metodológica trazia informações 
insuficientes. Resultados: As buscas levaram a 633 artigos que, após a aplicação dos critérios de inclusão e exclusão, formou-se um 
corpus de 76 produções, em sua maioria publicadas em língua inglesa e produzida nos EUA, Inglaterra e Brasil. Os resultados foram 
distribuídos em oito categorias temáticas e apontaram uma tendência do que tem sido o uso de medicamentos em idosos, destacando-se 
o uso de psicotrópicos, a polifarmácia, a prevenção de eventos adversos e adoção de tecnologias que facilitem o manejo dos medicamentos 
por parte do idoso. Os estudos apontam os riscos aos quais os idosos estão expostos devido às mudanças na metabolização e ao uso 
concomitante de vários medicamentos. Conclusão: Há uma forte preocupação com a melhora da comunicação entre profissionais e 
idosos no sentido de troca de informações sobre a terapia a fim de evitar maiores complicações à saúde dessa população.
DESCRITORES
Uso de Medicamentos; Idoso; Atenção Primária à Saúde; Enfermagem Geriátrica; Revisão.
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RESUMEN
Objetivo: Identificar el conocimiento producido sobre el uso de fármacos por ancianos en el marco de la atención primaria de 
salud, entre los años 2006 y 2014. Método: Revisión integradora llevada a cabo en las bases de datos PubMed, LILACS, BDENF y 
SCOPUS, incluyendo artículos de investigación cualitativa en portugués, inglés y español. Fueron excluidos aquellos cuya descripción 
metodológica traía informaciones insuficientes. Resultados: Las búsquedas llevaron a 633 artículos que, luego de la aplicación de los 
criterios de inclusión y exclusión, conformaron un corpus de 76 producciones, en su mayoría publicadas en lengua inglesa y producida 
en los EE.UU. y Brasil. Los resultados fueron distribuidos en ocho categorías temáticas y señalaron una tendencia de lo que está siendo 
el uso de fármacos en ancianos, destacándose el uso de psicotrópicos, la polifarmacia, la prevención de eventos adversos y la adopción 
de tecnologías que faciliten el manejo de los fármacos por parte del anciano. Los estudios señalan los riesgos a los que los ancianos 
están expuestos debido a los cambios en la metabolización y el uso concomitante de varios fármacos. Conclusión: Existe una fuerte 
preocupación por la mejora de la comunicación entre profesionales y ancianos con respecto al intercambio de informaciones acerca de 
la terapia a fin de evitar complicaciones a la salud de dicha población.
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